|

Intraoperative Dexmedetomidine and Coronary Artery Bypass Graft Surgery

RECRUITINGPhase 2/3Sponsored by University of Novi Sad
Actively Recruiting
PhasePhase 2/3
SponsorUniversity of Novi Sad
Started2024-04-03
Est. completion2024-07
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06378827

Summary

This is a prospective randomized clinical trial designed to determine the effect of intraoperative dexmedetomidine administration on renal function after coronary artery bypass graft surgery.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Elective coronary artery bypass graft surgery
* Age over 18 years
* ASA score 3 or 4
* Voluntary consent of the patient to participate in the research

Exclusion Criteria:

* Emergency coronary artery bypass graft surgery
* Chronic renal failure with eGFR \<60 ml/min/1.73m2
* Left ventricular ejection fraction \<30%
* 2nd or 3rd degree atrioventricular block
* Use of nephrotoxic agents such as aminoglycoside antibiotics or contrast agents within the last 48 hours
* Previous heart surgery or kidney surgery
* Allergy to dexmedetomidine

Conditions2

Acute Kidney InjuryHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.